1. Home
  2. QURE vs ETD Comparison

QURE vs ETD Comparison

Compare QURE & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • ETD
  • Stock Information
  • Founded
  • QURE 1998
  • ETD 1932
  • Country
  • QURE Netherlands
  • ETD United States
  • Employees
  • QURE N/A
  • ETD N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • ETD Home Furnishings
  • Sector
  • QURE Health Care
  • ETD Consumer Discretionary
  • Exchange
  • QURE Nasdaq
  • ETD Nasdaq
  • Market Cap
  • QURE 866.3M
  • ETD 763.7M
  • IPO Year
  • QURE 2007
  • ETD 1993
  • Fundamental
  • Price
  • QURE $64.16
  • ETD $27.69
  • Analyst Decision
  • QURE Strong Buy
  • ETD Hold
  • Analyst Count
  • QURE 12
  • ETD 2
  • Target Price
  • QURE $69.67
  • ETD $30.00
  • AVG Volume (30 Days)
  • QURE 7.5M
  • ETD 267.9K
  • Earning Date
  • QURE 11-04-2025
  • ETD 10-29-2025
  • Dividend Yield
  • QURE N/A
  • ETD 6.55%
  • EPS Growth
  • QURE N/A
  • ETD N/A
  • EPS
  • QURE N/A
  • ETD 2.01
  • Revenue
  • QURE $14,337,000.00
  • ETD $614,649,000.00
  • Revenue This Year
  • QURE N/A
  • ETD $1.12
  • Revenue Next Year
  • QURE $287.72
  • ETD $3.79
  • P/E Ratio
  • QURE N/A
  • ETD $13.75
  • Revenue Growth
  • QURE N/A
  • ETD N/A
  • 52 Week Low
  • QURE $5.23
  • ETD $24.55
  • 52 Week High
  • QURE $65.12
  • ETD $32.61
  • Technical
  • Relative Strength Index (RSI)
  • QURE 83.29
  • ETD 38.19
  • Support Level
  • QURE $50.80
  • ETD $28.43
  • Resistance Level
  • QURE $57.57
  • ETD $29.30
  • Average True Range (ATR)
  • QURE 5.17
  • ETD 0.55
  • MACD
  • QURE 1.67
  • ETD -0.15
  • Stochastic Oscillator
  • QURE 97.47
  • ETD 5.57

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

Share on Social Networks: